MECP2 mutations in humans with Rett syndrome are associated with impaired regulation of nucleolin, rRNA transcripts, and mTOR signaling through participation in post-transcriptional processing of certain microRNAs [44,45]. Here, MECP2 is linked to Rett syndrome.